144 related articles for article (PubMed ID: 32607524)
1. A Streamlined CyTOF Workflow To Facilitate Standardized Multi-Site Immune Profiling of COVID-19 Patients.
Geanon D; Lee B; Kelly G; Handler D; Upadhyaya B; Leech J; Herbinet M; Del Valle D; Gnjatic S; Kim-Schulze S; Merad M; Rahman A
medRxiv; 2020 Jun; ():. PubMed ID: 32607524
[TBL] [Abstract][Full Text] [Related]
2. A streamlined whole blood CyTOF workflow defines a circulating immune cell signature of COVID-19.
Geanon D; Lee B; Gonzalez-Kozlova E; Kelly G; Handler D; Upadhyaya B; Leech J; De Real RM; Herbinet M; Magen A; Del Valle D; Charney A; Kim-Schulze S; Gnjatic S; Merad M; Rahman AH
Cytometry A; 2021 May; 99(5):446-461. PubMed ID: 33496367
[TBL] [Abstract][Full Text] [Related]
3. Customizing Maxpar Direct Immune Profiling Assay with Additional Surface Marker and Intracellular Cytokine Staining Workflows for Expanded Mass Cytometry Panels.
Petes C; Li SKH; Mujib S; Poulin MM; Saederup N; Quong AA; Loh C
Methods Mol Biol; 2022; 2386():129-145. PubMed ID: 34766269
[TBL] [Abstract][Full Text] [Related]
4. Multi-site reproducibility of a human immunophenotyping assay in whole blood and peripheral blood mononuclear cells preparations using CyTOF technology coupled with Maxpar Pathsetter, an automated data analysis system.
Bagwell CB; Hunsberger B; Hill B; Herbert D; Bray C; Selvanantham T; Li S; Villasboas JC; Pavelko K; Strausbauch M; Rahman A; Kelly G; Asgharzadeh S; Gomez-Cabrero A; Behbehani G; Chang H; Lyberger J; Montgomery R; Zhao Y; Inokuma M; Goldberger O; Stelzer G
Cytometry B Clin Cytom; 2020 Mar; 98(2):146-160. PubMed ID: 31758746
[TBL] [Abstract][Full Text] [Related]
5. CyTOF
Iyer A; Hamers AAJ; Pillai AB
Front Immunol; 2022; 13():815828. PubMed ID: 35493491
[TBL] [Abstract][Full Text] [Related]
6. CyTOF: An Emerging Technology for Single-Cell Proteomics in the Mouse.
Tracey LJ; An Y; Justice MJ
Curr Protoc; 2021 Apr; 1(4):e118. PubMed ID: 33887117
[TBL] [Abstract][Full Text] [Related]
7. Validation of CyTOF Against Flow Cytometry for Immunological Studies and Monitoring of Human Cancer Clinical Trials.
Gadalla R; Noamani B; MacLeod BL; Dickson RJ; Guo M; Xu W; Lukhele S; Elsaesser HJ; Razak ARA; Hirano N; McGaha TL; Wang B; Butler M; Guidos CJ; Ohashi PS; Siu LL; Brooks DG
Front Oncol; 2019; 9():415. PubMed ID: 31165047
[TBL] [Abstract][Full Text] [Related]
8. Enumeration of major peripheral blood leukocyte populations for multicenter clinical trials using a whole blood phenotyping assay.
Hensley TR; Easter AB; Gerdts SE; De Rosa SC; Heit A; McElrath MJ; Andersen-Nissen E
J Vis Exp; 2012 Sep; (67):e4302. PubMed ID: 23007739
[TBL] [Abstract][Full Text] [Related]
9. Phenotyping of tumor infiltrating immune cells using mass-cytometry (CyTOF).
Maby P; Corneau A; Galon J
Methods Enzymol; 2020; 632():339-368. PubMed ID: 32000904
[TBL] [Abstract][Full Text] [Related]
10. High throughput and accurate serum proteome profiling by integrated sample preparation technology and single-run data independent mass spectrometry analysis.
Lin L; Zheng J; Yu Q; Chen W; Xing J; Chen C; Tian R
J Proteomics; 2018 Mar; 174():9-16. PubMed ID: 29278786
[TBL] [Abstract][Full Text] [Related]
11. Mass Cytometry Analysis of T-Helper Cells.
Subrahmanyam PB; Maecker HT
Methods Mol Biol; 2021; 2285():49-63. PubMed ID: 33928542
[TBL] [Abstract][Full Text] [Related]
12. Immune Profiling Mass Cytometry Assay Harmonization: Multicenter Experience from CIMAC-CIDC.
Sahaf B; Pichavant M; Lee BH; Duault C; Thrash EM; Davila M; Fernandez N; Millerchip K; Bentebibel SE; Haymaker C; Sigal N; Del Valle DM; Ranasinghe S; Fayle S; Sanchez-Espiridion B; Zhang J; Bernatchez C; Wu CJ; Wistuba II; Kim-Schulze S; Gnjatic S; Bendall SC; Song M; Thurin M; Lee JJ; Maecker HT; Rahman A
Clin Cancer Res; 2021 Sep; 27(18):5062-5071. PubMed ID: 34266889
[TBL] [Abstract][Full Text] [Related]
13. Mass cytometry for the multiplexed quantification and characterization of target expression on circulating cells in whole blood.
Stevens CR; Atkuri K; Menard DL; King LE; Neubert H; Goihberg P
Cytometry A; 2023 Aug; 103(8):631-645. PubMed ID: 36966446
[TBL] [Abstract][Full Text] [Related]
14. Erratum: High-Throughput Identification of Resistance to Pseudomonas syringae pv. Tomato in Tomato using Seedling Flood Assay.
J Vis Exp; 2023 Oct; (200):. PubMed ID: 37851522
[TBL] [Abstract][Full Text] [Related]
15. Mass Cytometry Assays for Antigen-Specific T Cells Using CyTOF.
Lin D; Maecker HT
Methods Mol Biol; 2018; 1678():37-47. PubMed ID: 29071674
[TBL] [Abstract][Full Text] [Related]
16. Cytometry of Mass for Murine Immunoprofiling.
Chandra V; McAllister F; Burks JK
Methods Mol Biol; 2022; 2435():129-137. PubMed ID: 34993943
[TBL] [Abstract][Full Text] [Related]
17. Development and validation of a high-parameter mass cytometry workflow to decipher immunomodulatory changes in celiac disease.
Estevam J; Krutzik P; Vander Tuig J; McAuliffe WJ; Smithson G
Cytometry B Clin Cytom; 2021 Jan; 100(1):92-102. PubMed ID: 33452759
[TBL] [Abstract][Full Text] [Related]
18. Stabilizing Antibody Cocktails for Mass Cytometry.
Schulz AR; Baumgart S; Schulze J; Urbicht M; Grützkau A; Mei HE
Cytometry A; 2019 Aug; 95(8):910-916. PubMed ID: 31058420
[TBL] [Abstract][Full Text] [Related]
19. Immunophenotyping of Human Peripheral Blood Mononuclear Cells by Mass Cytometry.
Heck S; Bishop CJ; Ellis RJ
Methods Mol Biol; 2019; 1979():285-303. PubMed ID: 31028645
[TBL] [Abstract][Full Text] [Related]
20. Platinum-Chimeric Carrier Cells for Ultratrace Cell Analysis in Mass Cytometry.
Li Y; Wang B; Ahmad Khan Z; He J; Cheung E; Su W; Wang A; Jiang H; Jiang L; Ding X
Anal Chem; 2023 Oct; 95(40):14998-15007. PubMed ID: 37767956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
